Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 96 of 1,261
  1. US 12077507

    Compositions and methods for treating cancer

    The Regents of the University of California Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  2. US 12076418

    Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo

    ENGENE, INC. Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  3. US 12077515

    Selective histone deacetylase inhibitors for the treatment of human disease

    Shuttle Pharmaceuticals, Inc. Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  4. US 12077498

    C4-carboxylic acid-substituted tryptamine derivatives and methods of using

    Enveric Biosciences Canada Inc. Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  5. US 12076316

    Levorphanol prodrugs and processes for making and using them

    Zevra Therapeutics, Inc. Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  6. US 12076405

    Heterocyclic degronimers for target protein degradation

    C4 THERAPEUTICS, INC. Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  7. US 12077782

    Viral clearance by low pH hold

    REGENERON PHARMACEUTICALS, INC. Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  8. US 12076371

    Activatable cytokine polypeptides and methods of use thereof

    Werewolf Therapeutics, Inc. Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  9. US 12076223

    Methods and tools for treating diseased tissue

    Covidien LP Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  10. US 12077772

    Transgene cassettes, AAV vectors and AAV viral vectors for the expression of human codon-optimized SLC6A1

    The Board of Regents of the University of Texas System Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  11. US 12077612

    Peptide compositions

    RHYTHM PHARMACEUTICALS, INC. Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  12. US 12077760

    DNA aptamers and use thereof for the treatment of cancer

    The Board of Regents of the University of Texas System Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  13. US 12076377

    Variant sulfatase enzymes with enhanced properties

    INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC. Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  14. US 12077551

    Zinc complex, preparation thereof and use thereof for trerapy of human and animal diseases

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU β€œZ THERAPEUTICS” Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  15. US 12077570

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  16. US 12077587

    Anti-CD8 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  17. US 12076332

    Treatment of lysosomal storage disorders

    The Regents of the University of California Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  18. US 12077555

    STAT degraders and uses thereof

    Kymera Therapeutics, Inc. Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  19. US 12077549

    Pentaaza macrocyclic ring complexes possessing oral bioavailability

    Galera Labs, LLC Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  20. US 12077543

    P2X3 and/or P2X2/3 compounds and methods

    Asana BioSciences, LLC Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  21. US 12077506

    Indane derivatives as hypoxia inducible factor-2(Ξ±) inhibitors

    NIKANG THERAPEUTICS, INC. Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  22. US 12076397

    Emulsion adjuvant for intramuscular, intradermal and subcutaneous administration

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  23. US 12076324

    Cancer treatments using combinations of CDK and ERK inhibitors

    Biomed Valley Discoveries, Inc. Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted
  24. US 12076301

    Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects

    The Regents of the University of California Β· Granted Sep 3, 2024 Β· Expires Aug 29, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.